BlossomHill Therapeutics General Counsel Vincent Paul Liptak buys USD 74,300 of common shares

Reuters2026/08/10 22:26

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BlossomHill Therapeutics General Counsel Vincent Paul Liptak increased his direct stake to 111,412 common shares via open-market purchases at USD 15.8–16.
He also reported 22,687 common shares held indirectly through the Walter T. Liptak Revocable Trust following a Series B preferred conversion.
Liptak received an employee stock option for 46,561 shares with a USD 16 exercise price.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blossomhill Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002143905-26-000003), on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BlossomHill Therapeutics General Counsel Vincent Paul Liptak buys USD 74,300 of common shares

You may also like

Crypto prices